“Viral Hepatitis Elimination in PWID: A Roadmap to Elimination in Italy”: Registrations now open

September 17, 2018 5:44 pm Published by Leave your thoughts1 Comment% Comments

This one-day workshop entitled “Viral Hepatitis Elimination in PWID: A Roadmap to Elimination in Italy” is co-organised by EASL International Liver Foundation (EILF) and the San Patrignano Community and will bring together leading experts in viral hepatitis, the drug treatment community in Italy and key stakeholders such as government officials, industry representatives, patient organisations and scientific societies.

The programme, presented by international experts, aims to provide the latest updates on viral hepatitis treatment in PWID while providing participants with the unique opportunity to network and exchange experiences and ideas for viral hepatitis elimination among people who inject drugs (PWID) in Italy.

Bringing all the stakeholders together, this workshop aims to not only kick-start the call to action for viral hepatitis elimination in PWID in Italy but to also generate a multi-stakeholder plan of action to turn this vision into reality.

We look forward to welcoming you to San Patrignano, Italy on 10 October 2018!

REGISTER NOW: 

Tags:

Categorised in:

This post was written by SOTO Admin

Event Alert: EILF Session at the Emirates Gastroenterology and Hepatology conference, 22-24 November 2018

June 14, 2018 3:08 pm Published by Leave your thoughts1 Comment% Comments

EILF will be heading back to Dubai in November 2018 to attend the Emirates Gastroenterology and Hepatology 2018 Conference in Dubai, where Prof. Massimo Colombo, Prof. Kosh Agarwal, Prof. Maria Buti and Prof. Guilio Marchesini  will hold an EILF Guidance on Liver Disease session.

 

 

Tags:

Categorised in:

This post was written by SOTO Admin

Event Alert: The first EILF School of Excellence, 28 September 2018

June 14, 2018 3:07 pm Published by Leave your thoughts1 Comment% Comments

EILF have recently embarked on a collaboration with the Emirates Gastroenterology and Hepatology Society and together, we will hold the first School of Excellence on 28 September 2018 in Dubai. This full day interactive school will be led by EILF and local experts providing a mix of state of the art lectures, debates and clinical case presentations.

 

 

Tags:

Categorised in:

This post was written by SOTO Admin

Event Alert: GOLD Summit II, 29 September 2018

June 14, 2018 3:06 pm Published by Leave your thoughts1 Comment% Comments

EILF are heading back to the Kingdom of Saudi Arabia for the second Guidance on Liver Disease (GOLD) Summit, which we are co-hosting in collaboration with the Saudi Association for Liver Diseases and Transplantation. EILF have selected esteemed faculty; Prof. Massimo Colombo, Prof. Xavier Forns, Prof. Sven Franque and Prof. George Papatheodoridis to provide state of the art updates and education on HBV, HCV, HCC, and NASH to local physicians at this interactive event.

Tags:

Categorised in:

This post was written by SOTO Admin

Event Alert: Workshop on viral Hepatitis elimination among people who inject drugs (PWID) in Italy on 10 October 2018

June 14, 2018 2:58 pm Published by Leave your thoughts1 Comment% Comments

In conjunction with San Patrignano, one of Europe’s largest drug rehabilitation centres, EILF will be holding a one-day workshop entitled “Viral Hepatitis Elimination in PWID: A Roadmap for Elimination in Italy” on 10 October 2018 in Rimini, Italy. This workshop will bring together leading experts in viral hepatitis, the drug treatment community in Italy and key stakeholders such as government officials, industry representatives, patient organisations and scientific societies. The workshop aims to not only kick start the call to action for viral hepatitis in PWID in Italy but also to generate a multi-stakeholder plan of action to turn this vision into a reality.

 

 

Tags:

Categorised in:

This post was written by SOTO Admin

Taking the EILF NAFLD Policy Review Europe wide

June 14, 2018 2:52 pm Published by Leave your thoughts1 Comment% Comments

In February this year, EILF kicked off Phase 1 of the EILF NAFLD Policy Review. This first of its kind research project aims to establish to what extent governments and key stakeholders like medical associations and patient groups are responding to the major public health threat that is non-alcoholic fatty liver disease (NAFLD)/ non-alcoholic steatohepatitis (NASH), raise awareness of the conditions and inform on the need for further initiatives and areas for collaboration. Phase 1 saw the review completed in 8 countries and the preliminary results showcased in a briefing chaired by Prof. Jeffrey Lazarus, and Prof. Quentin Anstee at the EASL International Liver Congress in April. Whilst the results are being written up for publication, Phase 2 will launch, seeing the review expanded to the remaining EU-28 countries.

 

 

Tags:

Categorised in:

This post was written by SOTO Admin

Keeping viral hepatitis elimination among haemophilia patients at the forefront of policy

June 14, 2018 2:44 pm Published by Leave your thoughts1 Comment% Comments

Brian O’Mahony, Chief Executive of the Irish Hemophilia Society gave a powerful presentation at the “Towards viral hepatitis elimination: An update on taking the micro-elimination path” meeting that EILF held earlier this year at the EASL International Liver Congress, making the point that “patients aren’t dying from haemophilia, they are dying from hepatitis C”.

As part of the EILF’s collaboration with the European Hemophilia Consortium, Prof. Massimo Colombo, EILF Chairman, who started his career studying and treating viral hepatitis in hemophilia, led a session on viral hepatitis elimination at the EHC Leadership Conference, ensuring that it remains at the forefront of the agenda.

The EHC Leadership Conference, held in Brussels on 8 June 2018, brought together leaders of the rare bleeding disorders community from across 45 European countries to exchange experiences, best practices, participate in interactive trainings and align policy on the key challenges facing the European haemophilia community.

 

Tags:

Categorised in:

This post was written by SOTO Admin

Update: EILF Mission to Uzbekistan

June 14, 2018 2:40 pm Published by Leave your thoughts1 Comment% Comments

On behalf of EILF, Prof. Mario Rizzetto recently completed a mission to Uzbekistan. The key purpose of this mission was to gain a first-hand view and in-depth understanding of the viral hepatitis situation in Uzbekistan and ascertain how EILF could potentially assist the country to help them achieve their viral hepatitis elimination targets.  During his visit, Prof. Rizzetto provided state of the art lectures on viral hepatitis in Tashkent, Samarkand and Navoy to local practitioners and met with clinicians, researchers and laboratory experts to discuss the situation. Prof. Rizzetto found that hepatitis D virus is of major national concern, which local experts estimate to account for more than 50% of liver morbidity and mortality. In conjunction with P

rof. Rizzetto, EILF are actively working on ways to take the findings of this mission forward.

Tags:

Categorised in:

This post was written by SOTO Admin

Prof. Jeffrey V. Lazarus elected EASL International Liver Foundation Vice-Chair

June 14, 2018 11:59 am Published by Leave your thoughts1 Comment% Comments

GENEVA 11.06.2018 – The EASL International Liver Foundation’s board of directors today elected Jeffrey V. Lazarus as the 1st Vice-Chair.

Prof Jeffrey V. Lazarus is the head of the Health Systems Research Group at the Barcelona Institute for Global Health (ISGlobal), Hospital Clínic. He also holds a position as an affiliated professor at CHIP, the WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen. He earlier served as Professor at LUHS Medical Academy, Lithuania. His decade-long career as health systems, HIV and hepatitis expert at WHO’s Regional Office for Europe was followed by three years at the Global Fund to Fight AIDS, Tuberculosis and Malaria. Prof Lazarus leaves the position as Board Chair of AFEW International to take up this new position. He continues on the steering committee of the two European Commission Joint Actions on infectious disease and as a member of the EASL International Liver Foundation.

“The foundation is extremely fortunate to have as its new Board Vice-Chair such an experienced and talented person,” said Prof. Massimo Colombo, Chairman of the EASL International Liver Foundation. “Jeffrey Lazarus has been a tremendously active board member. Over the past year, he has been co-leading key initiatives of our Foundation, such as the Viral Hepatitis Micro Elimination working group and the NAFLD Policy Review program. I know Jeffrey will be an excellent Vice-Chair for the Foundation and I look forward to continuing my strong working relationship with him.”

https://www.journal-of-hepatology.eu/article/S0168-8278(17)32141-4/fulltext

###

Based in Geneva, Switzerland, the EASL International Liver Foundation is a global non-profit organization, established in 2016 by the European Association for the Study of the Liver (EASL), committed to increasing the quality of life and reducing premature mortality for the greatest number of people by improving liver health.

 

 

 

 

Tags:

Categorised in:

This post was written by SOTO Admin